{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:44:32Z","timestamp":1786977872164,"version":"build-2736575974"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,14]]},"DOI":"10.7759\/cureus.30298","type":"journal-article","created":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T16:16:48Z","timestamp":1665764208000},"source":"Crossref","is-referenced-by-count":5,"title":["Oncocytic Cell Carcinoma of the Thyroid: A Case Report and an Overview of the Diagnosis, Treatment Modalities, and Prognosis"],"prefix":"10.7759","author":[{"given":"Ameena","family":"Syed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai Aishwarya","family":"Vanka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Escudero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hicham","family":"Krayem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-017-3370-x","article-title":"Survival and prognostic factors for survival, cancer specific survival and disease free interval in 239 patients with Hurthle cell carcinoma: a single center experience","volume":"17","author":"Oluic B","year":"2017","unstructured":"Oluic B, Paunovic I, Loncar Z, et al.. Survival and prognostic factors for survival, cancer specific survival and disease free interval in 239 patients with Hurthle cell carcinoma: a single center experience. BMC Cancer. 2017, 17:371. 10.1186\/s12885-017-3370-x","journal-title":"BMC Cancer"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910480106","article-title":"Trends in thyroid cancer incidence in Sweden, 1958-1981, by histopathologic type","volume":"48","author":"Pettersson B","year":"1991","unstructured":"Pettersson B, Adami HO, Wilander E, Coleman MP. Trends in thyroid cancer incidence in Sweden, 1958-1981, by histopathologic type. Int J Cancer. 1991, 48:28-33. 10.1002\/ijc.2910480106","journal-title":"Int J Cancer"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S119980","article-title":"H\u00fcrthle cell carcinoma: current perspectives","volume":"9","author":"Ahmadi S","year":"2016","unstructured":"Ahmadi S, Stang M, Jiang XS, Sosa JA. H\u00fcrthle cell carcinoma: current perspectives. Onco Targets Ther. 2016, 9:6873-84. 10.2147\/OTT.S119980","journal-title":"Onco Targets Ther"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.129.2.207","article-title":"Survival and prognosis in H\u00fcrthle cell carcinoma of the thyroid gland","volume":"129","author":"Bhattacharyya N","year":"2003","unstructured":"Bhattacharyya N. Survival and prognosis in H\u00fcrthle cell carcinoma of the thyroid gland. Arch Otolaryngol Head Neck Surg. 2003, 129:207-10. 10.1001\/archotol.129.2.207","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.5858\/2001-125-0541-CTCCAH","article-title":"Combined tall cell carcinoma and H\u00fcrthle cell carcinoma (collision tumor) of the thyroid","volume":"125","author":"Baloch ZW","year":"2001","unstructured":"Baloch ZW, Mandel S, LiVolsi VA. Combined tall cell carcinoma and H\u00fcrthle cell carcinoma (collision tumor) of the thyroid. Arch Pathol Lab Med. 2001, 125:541-3. 10.5858\/2001-125-0541-CTCCAH","journal-title":"Arch Pathol Lab Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-022-09707-3","article-title":"Overview of the 2022 WHO classification of thyroid neoplasms","volume":"33","author":"Baloch ZW","year":"2022","unstructured":"Baloch ZW, Asa SL, Barletta JA, et al.. Overview of the 2022 WHO classification of thyroid neoplasms. Endocr Pathol. 2022, 33:27-63. 10.1007\/s12022-022-09707-3","journal-title":"Endocr Pathol"},{"key":"ref7","article-title":"Harrison's Principles of Internal Medicine, 20e","author":"Jameson JL","year":"2018","unstructured":"Jameson JL, Fauci AS, Kasper DL, Hauser SL, Longo DL, Loscalzo J. Harrison's Principles of Internal Medicine, 20e. McGraw-Hill Education, United States; 2018."},{"key":"ref8","unstructured":"Dr. Gary Clayman, DMD, MD, FACS. (2022). https.\/\/www.thyroidcancer.com\/dr-gary-clayman-md?gclid=Cj0KCQjw8amWBhCYARIsADqZJoVxj2SzrXfNbqofYid1LFoCRsEkz9277xbBPF...."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/cncy.22101","article-title":"The prevalence and surgical outcomes of H\u00fcrthle cell lesions in FNAs of the thyroid: a multi-institutional study in 6 Asian countries","volume":"127","author":"Agarwal S","year":"2019","unstructured":"Agarwal S, Bychkov A, Jung CK, et al.. The prevalence and surgical outcomes of H\u00fcrthle cell lesions in FNAs of the thyroid: a multi-institutional study in 6 Asian countries. Cancer Cytopathol. 2019, 127:181-91. 10.1002\/cncy.22101","journal-title":"Cancer Cytopathol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-015-9367-6","article-title":"Poorly differentiated oncocytic (H\u00fcrthle cell) follicular carcinoma: an institutional experience","volume":"26","author":"Bai S","year":"2015","unstructured":"Bai S, Baloch ZW, Samulski TD, Montone KT, LiVolsi VA. Poorly differentiated oncocytic (H\u00fcrthle cell) follicular carcinoma: an institutional experience. Endocr Pathol. 2015, 26:164-9. 10.1007\/s12022-015-9367-6","journal-title":"Endocr Pathol"},{"key":"ref11","article-title":"Fine-Needle Aspiration Biopsy of the Thyroid Gland","author":"Dean DS","year":"2000","unstructured":"Dean DS, Gharib H. Fine-Needle Aspiration Biopsy of the Thyroid Gland. Endotext [Internet], South Dartmouth (MA); 2000."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1530\/endoabs.70.AEP983","article-title":"Hurthle cell carcinoma - a case report","volume":"70","author":"Tare R","year":"2020","unstructured":"Tare R, Lumi E,  Puca E, et al.. Hurthle cell carcinoma - a case report. Endocrine Abstracts. 2020, 70:AEP983. 10.1530\/endoabs.70.AEP983","journal-title":"Endocrine Abstracts"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1210\/js.2019-SUN-615","article-title":"SUN-615 hurdles in Hurthle cell cancer: a case report on Hurthle cell thyroid cancer with vertebral metastasis","volume":"3","author":"Viar JR","year":"2019","unstructured":"Viar JR, Kho S. SUN-615 hurdles in Hurthle cell cancer: a case report on Hurthle cell thyroid cancer with vertebral metastasis. J Endocr Soc. 2019, 3:SUN-615. 10.1210\/js.2019-SUN-615","journal-title":"J Endocr Soc"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19911101)68:9%3C1944::AID-CNCR2820680917%3E3.0.CO;2-I","article-title":"Follicular Hurthle cell tumors of the thyroid gland","volume":"68","author":"Carcangiu ML","year":"1991","unstructured":"Carcangiu ML, Bianchi S, Savino D, Voynick IM, Rosai J. Follicular Hurthle cell tumors of the thyroid gland. Cancer. 1991, 68:1944-53. 10.1002\/1097-0142(19911101)68:9%3C1944::AID-CNCR2820680917%3E3.0.CO;2-I","journal-title":"Cancer"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186%2Fs12885-017-3370-x","article-title":"Prognostic indications for H\u00fcrthle cell cancer","volume":"28","author":"Kushchayeva Y","year":"2004","unstructured":"Kushchayeva Y, Duh QY, Kebebew E, Clark OH. Prognostic indications for H\u00fcrthle cell cancer. World J Surg. 2004, 28:1266-70. 10.1186%2Fs12885-017-3370-x","journal-title":"World J Surg"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11176","article-title":"Prognostic factors in patients with H\u00fcrthle cell neoplasms of the thyroid","volume":"97","author":"Lopez-Penabad L","year":"2003","unstructured":"Lopez-Penabad L, Chiu AC, Hoff AO, Schultz P, Gaztambide S, Ordo\u00f1ez NG, Sherman SI. Prognostic factors in patients with H\u00fcrthle cell neoplasms of the thyroid. Cancer. 2003, 97:1186-94. 10.1002\/cncr.11176","journal-title":"Cancer"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-06915-0","article-title":"Clinical characteristics and prognostic factors of Hurthle cell carcinoma: a population based study","volume":"20","author":"Zhou X","year":"2020","unstructured":"Zhou X, Zheng Z, Chen C, et al.. Clinical characteristics and prognostic factors of Hurthle cell carcinoma: a population based study. BMC Cancer. 2020, 20:407. 10.1186\/s12885-020-06915-0","journal-title":"BMC Cancer"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.795184","article-title":"Oncocytic papillary thyroid carcinoma and oncocytic poorly differentiated thyroid carcinoma: clinical features, uptake, and response to radioactive iodine therapy, and outcome","volume":"12","author":"Lukovic J","year":"2021","unstructured":"Lukovic J, Petrovic I, Liu Z, et al.. Oncocytic papillary thyroid carcinoma and oncocytic poorly differentiated thyroid carcinoma: clinical features, uptake, and response to radioactive iodine therapy, and outcome. Front Endocrinol (Lausanne). 2021, 12:795184. 10.3389\/fendo.2021.795184","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1177\/000348940911800510","article-title":"Clinicopathologic features and outcome of the oncocytic variant of papillary thyroid carcinoma","volume":"118","author":"Gross M","year":"2009","unstructured":"Gross M, Eliashar R, Ben-Yaakov A, Weinberger JM, Maly B. Clinicopathologic features and outcome of the oncocytic variant of papillary thyroid carcinoma. Ann Otol Rhinol Laryngol. 2009, 118:374-81. 10.1177\/000348940911800510","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"ref20","article-title":"Stell and Maran\u2019s Textbook of Head and Neck Surgery and Oncology Fifth Edition","author":"Watkinson J","year":"2012","unstructured":"Watkinson J, Gilbert RW. Stell and Maran\u2019s Textbook of Head and Neck Surgery and Oncology Fifth Edition. Taylor & Francis, UK; 2012."},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2013.04.033","article-title":"Patients with follicular and Hurthle cell microcarcinomas have compromised survival: a population level study of 22,738 patients","volume":"154","author":"Kuo EJ","year":"2013","unstructured":"Kuo EJ, Roman SA, Sosa JA. Patients with follicular and Hurthle cell microcarcinomas have compromised survival: a population level study of 22,738 patients. Surgery. 2013, 154:1246-53; discussion 1253-4. 10.1016\/j.surg.2013.04.033","journal-title":"Surgery"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7819-2-27","article-title":"H\u00fcrthle cell carcinoma: diagnostic and therapeutic implications","volume":"2","author":"Hanief MR","year":"2004","unstructured":"Hanief MR, Igali L, Grama D. H\u00fcrthle cell carcinoma: diagnostic and therapeutic implications. World J Surg Oncol. 2004, 2:27. 10.1186\/1477-7819-2-27","journal-title":"World J Surg Oncol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/s0039-6060(96)80046-8","article-title":"H\u00fcrthle cell carcinoma of the thyroid gland: prognostic factors and results of surgical treatment","volume":"120","author":"McDonald MP","year":"1996","unstructured":"McDonald MP, Sanders LE, Silverman ML, Chan H-S, Buyske J. H\u00fcrthle cell carcinoma of the thyroid gland: prognostic factors and results of surgical treatment. Surgery. 1996, 120:1000-5. 10.1016\/s0039-6060(96)80046-8","journal-title":"Surgery"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1177%2F107327481101800203","article-title":"A risk-adapted approach to the use of radioactive iodine and external beam radiation in the treatment of well-differentiated thyroid cancer","volume":"18","author":"Tuttle RM","year":"2011","unstructured":"Tuttle RM, Rondeau G, Lee NY. A risk-adapted approach to the use of radioactive iodine and external beam radiation in the treatment of well-differentiated thyroid cancer. Cancer Control. 2011, 18:89-95. 10.1177%2F107327481101800203","journal-title":"Cancer Control"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11060849","article-title":"10-year locoregional control with postoperative external beam radiotherapy in patients with locally advanced high-risk non-anaplastic thyroid carcinoma de novo or at relapse, a propensity score analysis","volume":"11","author":"Servagi Vernat S","year":"2019","unstructured":"Servagi Vernat S, Khalifa J, Sun XS, et al.. 10-year locoregional control with postoperative external beam radiotherapy in patients with locally advanced high-risk non-anaplastic thyroid carcinoma de novo or at relapse, a propensity score analysis. Cancers (Basel). 2019, 11:10.3390\/cancers11060849","journal-title":"Cancers (Basel)"},{"key":"ref26","article-title":"Doxorubicin","author":"Johnson-Arbor K","year":"2022","unstructured":"Johnson-Arbor K, Dubey R. Doxorubicin. StatPearls [Internet], Treasure Island (FL); 2022."},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1406470","article-title":"Lenvatinib versus placebo in radioiodine-refractory thyroid cancer","volume":"372","author":"Schlumberger M","year":"2015","unstructured":"Schlumberger M, Tahara M, Wirth LJ, et al.. Lenvatinib versus placebo in radioiodine-refractory thyroid cancer. N Engl J Med. 2015, 372:621-30. 10.1056\/NEJMoa1406470","journal-title":"N Engl J Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-1923","article-title":"Treatment with tyrosine kinase inhibitors for patients with differentiated thyroid cancer: the M. D. Anderson experience","volume":"95","author":"Cabanillas ME","year":"2010","unstructured":"Cabanillas ME, Waguespack SG, Bronstein Y, et al.. Treatment with tyrosine kinase inhibitors for patients with differentiated thyroid cancer: the M. D. Anderson experience. J Clin Endocrinol Metab. 2010, 95:2588-95. 10.1210\/jc.2009-1923","journal-title":"J Clin Endocrinol Metab"},{"key":"ref29","article-title":"Hurthle Cell Thyroid Carcinoma","author":"Fariduddin MM","year":"2021","unstructured":"Fariduddin MM, Syed W. Hurthle Cell Thyroid Carcinoma. StatPearls [Internet], Treasure Island (FL); 2021."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/104174-oncocytic-cell-carcinoma-of-the-thyroid-a-case-report-and-an-overview-of-the-diagnosis-treatment-modalities-and-prognosis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:41:48Z","timestamp":1707507708000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/104174-oncocytic-cell-carcinoma-of-the-thyroid-a-case-report-and-an-overview-of-the-diagnosis-treatment-modalities-and-prognosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,14]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7759\/cureus.30298","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10,14]]}}}